Abstract
We used oligonucleotide microarrays to profile the expression of chronic lymphocytic leukemia (CLL) B cells from eight patients compared with CD5-expressing normal B cells from four donors and with pooled normal circulating B cells. Of 6790 genes examined, we identified 87 genes that were differentially expressed at least two-fold between CLL and the normal B cells. CLL cells significantly down-regulated transcripts from CD1c and CD1d genes, which encode proteins known to present lipid antigen and mediate innate and adaptive immunity. The expression pattern was also consistent with reduced signaling by interferon gamma but increased response to interleukin 4 in leukemic cells. CLL cells increased the expression of several collagen-associated extracellular matrix and adhesion molecules, up-regulated many genes involved in intracellular protein transport and processing, while downregulating genes involved in proliferation and metabolism. Based on the expression pattern, we propose that CLL-B cells prolong their survival through increased interaction with survival factors such as IL-4, and through various mechanisms of evading the immune response, such as turning off the expression of CD1c and CD1d, reducing immunogenic response to interferon gamma, inactivating T cell in B–T interaction and increasing the expression of immunoglobulin receptors which neutralize antibody-dependent cell-mediated cytotoxicity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parker SL, Tong T, Bolden S, Wingo PA . Cancer statistics, 1997 CA Cancer J Clin 1997 47: 5–27
Caligaris-Cappio F . B-chronic lymphocytic leukemia: a malignancy of anti-self B cells Blood 1996 87: 2615–2620
Kipps TJ . Chronic lymphocytic leukemia Curr Opin Hematol 1997 4: 268–276
Wierda WG, Kipps TJ . Chronic lymphocytic leukemia Curr Opin Hematol 1999 6: 253–261
Lydyard PM, Lamour A, MacKenzie LE, Jamin C, Mageed RA, Youinou P . CD5+ B cells and the immune system Immunol Lett 1993 38: 159–166
Kipps TJ, Robbins BA, Tefferi A, Meisenholder G, Banks PM, Carson DA . CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies Am J Pathol 1990 136: 809–816
Kipps TJ, Rassenti LZ, Duffy S, Johnson T, Kobayashi R, Carson DA . Immunoglobulin V gene expression in CD5 B-cell malignancies Ann NY Acad Sci 1992 651: 373–383
Kipps TJ, Duffy SF . Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes J Clin Invest 1991 87: 2087–2096
Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Neri A, Califano A, Dalla-Favera R . Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells J Exp Med 2001 194: 1625–1638
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES . Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 1999 286: 531–537
Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 2000 403: 503–511
Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO . The transcriptional program in the response of human fibroblasts to serum Science 1999 283: 83–87
Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR . Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation Proc Natl Acad Sci USA 1999 96: 2907–2912
Karpf AR, Peterson PW, Rawlins JT, Dalley BK, Yang Q, Albertsen H, Jones DA . Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells Proc Natl Acad Sci USA 1999 96: 14007–14012
Hofmann WK, de Vos S, Tsukasaki K, Wachsman W, Pinkus GS, Said JW, Koeffler HP . Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray Blood 2001 98: 787–794
Dorfman DM, Pinkus GS . Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23 Mod Pathol 1994 7: 326–331
Eisen MB, Spellman PT, Brown PO, Botstein D . Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 1998 95: 14863–14868
Ranheim EA, Kipps TJ . Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal J Exp Med 1993 177: 925–935
Dazzi F, D'Andrea E, Biasi G, De Silvestro G, Gaidano G, Schena M, Tison T, Vianello F, Girolami A, Caligaris-Cappio F . Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens Clin Immunol Immunopathol 1995 75: 26–32
Zhou LJ, Tedder TF . Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily J Immunol 1995 154: 3821–3835
Ranheim EA, Cantwell MJ, Kipps TJ . Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells Blood 1995 85: 3556–3565
Park SH, Bendelac A . CD1-restricted T-cell responses and microbial infection Nature 2000 406: 788–792
Nishimura T, Kitamura H, Iwakabe K, Yahata T, Ohta A, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nakui M, Sekimoto M, Koda T . The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes Int Immunol 2000 12: 987–994
Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A, Bach JF, Monteiro RC . Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes J Exp Med 1998 188: 1831–1839
Smyth MJ, Thia KY, Street SE, Cretney E, Trapani JA, Taniguchi M, Kawano T, Pelikan SB, Crowe NY, Godfrey DI . Differential tumor surveillance by natural killer (NK) and NKT cells J Exp Med 2000 191: 661–668
Fournier S, Yang LP, Delespesse G, Rubio M, Biron G, Sarfati M . The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia Br J Haematol 1995 89: 373–379
Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M . Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression J Exp Med 1992 176: 1319–1326
Pu QQ, Bezwoda WR . Interleukin-4 prevents spontaneous in-vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity Br J Haematol 1997 98: 413–417
Williams JF, Petrus MJ, Wright JA, Husebekk A, Fellowes V, Read EJ, Gress RE, Fowler DH . fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous fasL-expressing T cells Br J Haematol 1999 107: 99–105
Mu X, Kay NE, Gosland MP, Jennings CD . Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells Br J Haematol 1997 96: 733–735
de Totero D, Reato G, Mauro F, Cignetti A, Ferrini S, Guarini A, Gobbi M, Grossi CE, Foa R . IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia Br J Haematol 1999 104: 589–599
Mainou-Fowler T, Miller S, Proctor SJ, Dickinson AM . The levels of TNF alpha, IL4 and IL10 production by T-cells in B-cell chronic lymphocytic leukaemia (B-CLL) Leuk Res 2001 25: 157–163
Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD . IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 2001 410: 1107–1111
Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD . Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice Proc Natl Acad Sci USA 1998 95: 7556–7561
Colgan SP, Morales VM, Madara JL, Polischuk JE, Balk SP, Blumberg RS . IFN-gamma modulates CD1d surface expression on intestinal epithelia Am J Physiol 1996 271: C276–C283
Callanan MB, Le Baccon P, Mossuz P, Duley S, Bastard C, Hamoudi R, Dyer MJ, Klobeck G, Rimokh R, Sotto JJ, Leroux D . The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma Proc Natl Acad Sci USA 2000 97: 309–314
Clynes RA, Towers TL, Presta LG, Ravetch JV . Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets Nat Med 2000 6: 443–446
Svensson L, Aszodi A, Reinholt FP, Fassler R, Heinegard D, Oldberg A . Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon J Biol Chem 1999 274: 9636–9647
Olsen BR . Collagen IX Int J Biochem Cell Biol 1997 29: 555–558
Liotta LA, Kohn EC . The microenvironment of the tumour–host interface Nature 2001 411: 375–379
de la Fuente MT, Casanova B, Garcia-Gila M, Silva A, Garcia-Pardo A . Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax Leukemia 1999 13: 266–274
Lagneaux L, Delforge A, Bron D, De Bruyn C, Stryckmans P . Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells Blood 1998 91: 2387–2396
Lagneaux L, Delforge A, De Bruyn C, Bernier M, Bron D . Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells Leuk Lymphoma 1999 35: 445–453
Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC . The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules J Exp Med 2000 191: 77–88
Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M . CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs Cell 1999 99: 23–33
Kneitz C, Goller M, Wilhelm M, Mehringer C, Wohlleben G, Schimpl A, Tony HP . Inhibition of T cell/B cell interaction by B-CLL cells Leukemia 1999 13: 98–104
Yellin MJ, Sinning J, Covey LR, Sherman W, Lee JJ, Glickman-Nir E, Sippel KC, Rogers J, Cleary AM, Parker M . T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity J Immunol 1994 153: 666–674
Cantwell M, Hua T, Pappas J, Kipps TJ . Acquired CD40-ligand deficiency in chronic lymphocytic leukemia Nat Med 1997 3: 984–989
Khan AA, Bose C, Yam LS, Soloski MJ, Rupp F . Physiological regulation of the immunological synapse by agrin Science 2001 292: 1681–1686
Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML . The immunological synapse Annu Rev Immunol 2001 19: 375–396
O'Hagan RC, Schreiber-Agus N, Chen K, David G, Engelman JA, Schwab R, Alland L, Thomson C, Ronning DR, Sacchettini JC, Meltzer P, DePinho RA . Gene-target recognition among members of the myc superfamily and implications for oncogenesis Nat Genet 2000 24: 113–119
Lloberas J, Maki RA, Celada A . Repression of major histocompatibility complex I–A beta gene expression by dbpA and dbpB (mYB-1) proteins Mol Cell Biol 1995 15: 5092–5099
Hong NA, Flannery M, Hsieh SN, Cado D, Pedersen R, Winoto A . Mice lacking Dad1, the defender against apoptotic death-1, express abnormal N-linked glycoproteins and undergo increased embryonic apoptosis Dev Biol 2000 220: 76–84
Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, Rai K, Hines J, Reed JC . Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses Blood 1998 91: 3379–3389
Schweizer A, Rohrer J, Jeno P, DeMaio A, Buchman TG, Hauri HP . A reversibly palmitoylated resident protein (p63) of an ER-Golgi intermediate compartment is related to a circulatory shock resuscitation protein J Cell Sci 1993 104: 685–694
Braesch-Andersen S, Stamenkovic I . Sialylation of the B lymphocyte molecule CD22 by alpha 2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion J Biol Chem 1994 269: 11783–11786
Acknowledgements
We are grateful to Lenn Flechter for help with clinical samples. The GeneChip array hybridizations were performed in the Affymetrix Academic User Center. The authors acknowledge the support of NIH grants 5R01CA056764-08 and P01HG01323 for this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zheng, Z., Venkatapathy, S., Rao, G. et al. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells. Leukemia 16, 2429–2437 (2002). https://doi.org/10.1038/sj.leu.2402711
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402711
Keywords
This article is cited by
-
The function of γδ T cells in humoral immune responses
Inflammation Research (2023)
-
Pla2g2a promotes innate Th2-type immunity lymphocytes to increase B1a cells
Scientific Reports (2022)
-
ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro
Molecular Cancer (2015)
-
Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression
International Journal of Hematology (2012)
-
Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma
Annals of Hematology (2011)